scPharmaceuticals Inc.
SCPHDelisted Oct 7, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001604950
scPharmaceuticals Inc. was delisted on Oct 7, 2025; its insiders filed their last Form 4 on Oct 7, 2025; 110 institutions reported holding it in 13F filings for Q3 2025, worth $232.3M in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding scPharmaceuticals Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 81 | 1 | 73 | −7 |
| Shares | 28.5M | 425 | 29.9M | +1.40M (+4.9%) |
| Value | $290.8M | $4.33K | $213.1M | −$77.7M (−26.7%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held scPharmaceuticals Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| AlphaCentric Advisors LLC | 125,000 | $890.0K | 0.51% |
| Tejara Capital Ltd | 101,414 | $722.1K | 0.41% |
| Goldman Sachs Group Inc | 20,894 | $148.8K | 0.00% |
| Captrust Financial Advisors | 11,500 | $81.9K | 0.00% |
| AQR Capital Management LLC | 10,844 | $77.2K | 0.00% |
| Alliancebernstein L.P. | 10,370 | $73.8K | 0.00% |
| Russell Investments Group, Ltd. | 35 | $249 | 0.00% |
Sold out (14)
Institutions that held scPharmaceuticals Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| EAM Investors, LLC | 265,528 | $2.71M |
| Renaissance Technologies LLC | 55,886 | $569.0K |
| Jump Financial, LLC | 40,200 | $409.6K |
| Jane Street Group, LLC | 36,204 | $368.9K |
| Boothbay Fund Management, LLC | 30,570 | $311.5K |
| Connor, Clark & Lunn Investment Management Ltd. | 28,206 | $287.4K |
| The PNC Financial Services Group, Inc. | 25,000 | $254.8K |
| Simplex Trading, LLC | 23,528 | $239.0K |
| Gsa Capital Partners LLP | 22,609 | $230.0K |
| Two Sigma Advisers, LP | 18,000 | $183.4K |
| Dorsey Wright & Associates | 3,300 | $33.6K |
| Impact Partnership Wealth, LLC | 195 | $1.99K |
| Federated Hermes, Inc. | 55 | $560 |
| Tucker Asset Management LLC | 28 | $285 |
Not filed for Q3 2023 yet (1)
Institutions that held scPharmaceuticals Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| BDO Wealth Advisors, LLC | 425 | $4.33K |